Chair Lecia V. Sequist, MD, MPH, and Patrick Nana-Sinkam, MD, FCCP, prepared useful Practice Aids pertaining to lung cancer for this CME/MOC/AAPA/IPCE activity titled “Screening and Early Intervention as the Keys to Success in Lung Cancer: A Practical Approach to Implementing Lung Cancer Screening for High-Risk Individuals.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/46VvwoP. CME/MOC/AAPA/IPCE credit will be available until April 16, 2025.

1. Lung Cancer Screening: Guideline Updates
Full abbreviations, accreditation, and disclosure information available at PeerView.com/PJP40
1. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening.
USPSTF: Updated Lung Cancer Screening Guidelines1
Mar 2021: USPSTF expanded its recommendation for screening to include a larger age range and more current and former smokers.
Population
Criteria
Grade
2021 USPSTF Guidelines
Recommendation
2013-2021 USPSTF Guidelines
Adults aged 50-80 years
who have a 20 pack-year
history and currently
smoke or have quit within
the past 15 years
Age, y • 55-80 • 50-80
• 20 or more pack-years (this means one pack a day for
20 years, two packs a day for 10 years, etc.)
• 30 or more pack-years (this means one pack a day
for 30 years, two packs a day for 15, etc.)
• Current smoker or quit within the last 15 years
Smoking history
Smoking status
B
• Annual screening for lung cancer with low-dose computed tomography
(LDCT) in adults aged 50-80 years who have a 20 pack-year history and
currently smoke or have quit within the past 15 years
• Screening should be discontinued once a person has not smoked for 15
years or develops a health problem that substantially limits life expectancy
or the ability or willingness to have curative lung surgery
USPSTF also recommends using age and smoking history to determine screening eligibility rather
than more elaborate risk prediction models, because there is insufficient evidence to assess whether
risk prediction model–based screening would improve outcomes relative to using the risk factors
of age and smoking history for broad implementation in primary care.
DEFINING HIGH RISK
!

2. Lung Cancer Screening: Guideline Updates
Full abbreviations, accreditation, and disclosure information available at PeerView.com/PJP40
2023 American Cancer Society: Updated Lung Cancer Screening Guidelines2
2. Wolf AMD et al. CA Cancer J Clin. 2024;74:50-81.
Eligibility Old Guidelines (2013 [2018])
Updated Guidelines (2023)
Age, y
Smoking status
Smoking history
Recommendation
Health status exclusions
Decision-making about
screening
Ensure adequate knowledge
about lung cancer screening
and time for clinicians to
incorporate SDM into practice
Engage the community in
raising awareness of lung
cancer screening (eg, assist with
trust, address misconceptions)
Consider personalized
SDM tools for different
patient populations
Use SDM tools (eg, LungCARE)
See the next page for resources
Integration of navigators (eg, lay
navigators) to facilitate identification
of eligible patients, introduction of
SDM, smoking cessation, and proper
follow-up
50-80
Current or previous smoker
Current smoker or previous smoker who quit
within the past 15 years
≥30 pack-year history
Annual screening with LDCT
≥20 pack-year history
Annual screening with LDCT
• Health conditions that may increase harm or hinder
further evaluation, surgery, or treatment for
lung cancer
• Comorbid conditions that limit life expectancy
<5 years, not willing to accept treatment for
screen-detected cancer
• Life-limiting comorbid condition
• Metallic implants or devices in the chest or back
• Requirement for home oxygen supplementation
• Undergo a process of shared decision-making (SDM)
with a qualified HCP that includes information about
benefits, limitations, and harms of screening with
LDCT, and
• A person who currently smokes should be advised to
quit and offered counseling and pharmacotherapy to
assist in quitting
• Undergo a process of SDM that includes information
about potential benefits, limitations, and harms of
screening with LDCT, and
• Have access to high-volume, high-quality lung
cancer screening and treatment center, and
• A person who currently smokes should receive
evidence-based smoking-cessation counseling
55-74
KEY UPDATE IS TO REMOVE THE 15-YEAR QUIT LIMITATION FROM THE GUIDELINES
Keys to an Effective Uptake of Lung Cancer Screening

3. Lung Cancer Screening: Guideline Updates
Full abbreviations, accreditation, and disclosure information available at PeerView.com/PJP40
ACR® Lung Cancer Screening CT
Incidental Findings
Quick Reference Guide
ACR® Lung Cancer
Screening Resources
SDM Aids
• This Quick Guide is intended for use by lung cancer screening (LCS) program
coordinators and nurse navigators as they assist in the care coordination of patients
being screened for lung cancer in collaboration with the referring providers
• The Quick Guide lists common incidental findings on LCS CT and the typical
management and/or appropriate follow–up recommendations
• Access here: https://www.acr.org/-/media/ACR/Files/Lung-Cancer-Screening-
Resources/LCS-Incidental-Findings-Quick-Guide.pdf
• National Lung Cancer Screening Day
• Pink & Pearls Campaign
• Access here: https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources
• Should I Screen?
– A tool that can be used by a provider to assess a patient’s risk of developing lung
cancer in the next 6 years, which can be incorporated into an SDM conversation
with patients; patients can also use it to determine if they qualify for lung cancer
screening
• Access here: https://shouldiscreen.com/English/home
• Decision-Making Tool
– A tool that can be used by a provider to assess a patient’s risk of developing lung
cancer in the next 6 years; patients can also use it to determine if they qualify for
lung cancer screening
• Access here: https://www.acr.org/-/media/ACR/Files/Lung-Cancer-Screening-
Resources/May_Lung_INFO_LHP-FINAL_R5.pdf
Lung Cancer Screening Resources for Clinicians

4. Lung Cancer Screening:
LUNGevity Resources for Patients
Full abbreviations, accreditation, and disclosure information available at PeerView.com/PJP40
Clinicians are encouraged to share the following printable page with patients who are candidates
for lung cancer screening, as well as those patients who are already undergoing lung cancer
screening. The hand-out offers patient-centered information and resources through LUNGevity
to educate and encourage patients to be more active participants in their healthcare decisions.
LUNGevity also provides support and community to all individuals affected by lung cancer.
Printable Patient Hand-Out You Can Use in Your Practice

5. Lung Cancer Screening Resources for You
and Your Loved Ones From LUNGevity Foundation
Visit LUNGevity’s comprehensive website on risk factors and how lung cancer develops:
https://www.lungevity.org/screening-for-lung-cancer/learn-about-your-risk
LEARN ABOUT YOUR OR A LOVED ONE’S RISK OF DEVELOPING LUNG CANCER
Learn what lung cancer screening is and who should be screened for lung cancer:
https://www.lungevity.org/screening-for-lung-cancer/early-lung-cancer-screening
WHAT IS LUNG CANCER SCREENING?
Take this short quiz to check if you or a loved one qualify for lung cancer screening:
https://www.lungevity.org/screening-for-lung-cancer/early-lung-cancer-screening/are-you-eligible-for-screening
WHO IS ELIGIBLE FOR LUNG CANCER SCREENING?
Get answers to commonly asked questions about what happens after lung cancer screening:
https://www.lungevity.org/screening-for-lung-cancer/understanding-your-results
WHAT COMES AFTER LUNG CANCER SCREENING?
Access educational materials for patients and caregivers from LUNGevity:
https://www.lungevity.org/for-patients-caregivers/helpful-resources/get-educational-materials
PRINTABLE EDUCATIONAL MATERIALS ON LUNG CANCER SCREENING
Usted puede encontrarlos aquí:
https://www.lungevity.org/for-patients-caregivers/helpful-resources/get-educational-materials/materiales-educativos-sobre-el
MATERIALES EDUCATIVOS SOBRE EL CÁNCER DE PULMÓN